AAIC 2017 | A need for speed
Tetsu Maruyama
Very few new drugs to help treat dementia patients have been developed in recent years. Tetsu Maruyama, PhD, Chief Scientific Officer of the Dementia Discovery Fund (DDF) talks to us about why this progress has been so slow, offers some suggestions on the ways in which this could be improved, and discusses the objectives of the DDF. This interview was recorded at the 2017 Alzheimer’s Association International Conference (AAIC) held in London, UK.
Related videos
1:31
DEMON network for dementia data science collaboration
David Llewellyn
5:43
Microglial activation in Alzheimer's
Paul Edison
2:58
The protective effect of NTF
Wipawan Thangnipon
1:54
DPUK x Uni of Exeter Dementias Datathon
David Llewellyn
2:06
Dementias Platform UK Datathons: get involved!
Sarah Bauermeister
